Management of Cystic Fibrosis before and after Lung Transplantation

Madden BP , Hodson ME , Tsang V Intermediate-results of heart lung transplantation for cystic fibrosis. Lancet 1992; 339: 1583–7.

Hosenpud JD , Novick RJ , Bennet LE , Keck BM , Fiol B , Daily OP . The registry of the international society for heart and lung transplantation: thirteenth official report—1996. J Heart Lung Transplant 1996; 15: 655–74.

Abbott J , Dodd M , Webb AK . Different perceptions of disease severity and self care between patients with cystic fibrosis, their close companions, and physician. Thorax 1995; 5: 794–6.

Kerem E , Reisman J , Corey M , Canny GJ , Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992; 326: 1887–91.

Moorcroft AJ , Webb AK , Dodd ME . Preterminal disease and dying in adult cystic fibrosis. Thorax 1994; 9: 393.

Nelson JW , Butler SL , Krieg D , Govan JR . Virulence factors of Burkholderia cepacia. FEMS Immunol Med Microbiol 1994; 8: 89–98.

Dennis CM , McNeill KD , Dunning J Heart-Lung-Liver Transplantation. J Heart Lung Transplant 1996; 15: 536–8.

Corey M , McLaughlin FJ , Williams M , Levison H. A comparison of survival, growth, and pulmonary function in patients with cvstic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41: 583–91.

Naon H , Hack S , Shelton MT Resting energy expenditure; evolution during antibiotic treatment for pulmonary exacerbation in cystic fibrosis. Chest 1993; 103: 1819–25.

Dennis C , Caine N , Sharpies L Heart lung transplantation for endstage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant 1993; 12: 893–902.

Elborn JS , Jagoe T , Shale DJ . Metabolic and respiratory consequences of a glucose load in hypoxic patients with cystic fibrosis. Nature Med 1992; 61: 188–92.

Hodson ME , Madden BP , Steven MH Non-invasive mechanical ventilation for cystic fibrosis patients—a potential bridge to transplantation. Eur Respir J 1991; 4: 524–7.

Piper AJ , Parker S , Torzillo PJ , Sullivan CE , Bye PT . Nocturnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure. Chest 1992; 102: 846–50.

Stead RJ , Davidson TI , Duncan FR , Hodson ME , Batten JC . Use of a totally implantable system for venous access in cystic fibrosis. Thorax 1987; 42: 149–50.

Snell GI , de Hoyos A , Krajden M Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993; 103: 466–7.

Ramirez JC , Patterson GA , Winton TL , De Hoyos AL , Miller JD , Maurer JR . Bilateral lung transplantation for cystic fibrosis. J Thorac Cardiovasc Surg 1992; 103: 287–94.

Yamagishi Y , Fujita K , Takigawa K , Negayama T , Nakazawa T , Takahara J. Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients. Chest 1993; 103: 1706–9.

Egan JJ , Chadwick P , Lowe L , Woodcock AA . The potential of nosocomial transmissions of Pseudomonas cepacia exists at cardiopulmonary transplant centres. Chest 1994; 105(5): 1630–1.

Flume PA , Egan TM , Paradowiski LJ , Detterbeck FC , Thomson JT , Yankaskas JR . Infectious complications of lung transplantation; impact of cystic fibrosis. Am J Kespir Crit Care Med 1994; 149: 1601–7.

Egan J , McNeil K , Bookless B Post transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia. Lancet 1994; 344: 552–3.

Ryan PJ , Stableforth DE . Referral for lung transplantation: experience of a Birmingham adult cystic fibrosis centre between 1987 and 1994. Thorax 1996; 51: 302–5.

Elborn JS , Dodd M , Maddison J Clinical and inflammatory responses in CF patients infected with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr Pulmonol 1994; 10: S287.

Shaw D , Poxton IR , Govan JRW . Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol Med Microbiol 1995; 11: 99–106.

Kramer MR , Denning DW , Marshall SE Ulcerative tracheobronchitis after lung transplantation: a new form of invasive aspergillosis. Am Rev Kespir Dis 1991; 144: 552–6.

Tazelaar HD , Baird AM , Mill M , Grimes MM , Schulman LL , Smith CR . Bronchocentric mycosis occurring in transplant recipients. Chest 1989; 96: 92–5.

Yacoub MH , Banner NR , Khaghani A Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation. J Heart Transplant 1990; 9: 459–67.

Egan JJ , Krysiak P , El-Gamel A Heart-Lung or double lung transplant for cystic fibrosis/bronchiectasis. Thorax 1994; 49: 1050P.

Au J , Hawkins T , Venables C Upper gastrointestinal dysmotility in heart-lung transplant recipients. Ann Thor Surg 1993; 55: 94–7.

Koretz RL . Nutritional supplementation in the ICU. Am J Kespir Crit Care Med 1995; 151: 570–3.

Bonnefoy-Berard N , Revillard JP . Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. J Heart Lung Transplant 1996; 15: 435–2.

Halloran PF . Molecular mechanisms of new immunosuppressants. Clin Transpl 1996; 10: 118–23.

Kahan BD . Cyclosporine. N Engl Med J 1989; 321(25): 1725–38.

Kovarik JM , Mueller EA , van Bree JB Cyclosporin pharmacokinetics and variability from a micoemulsion formulation— a multicenter investigation in kidney transplant patients. Transplantation 1994; 58: 658–63.

Jennery A , O'Sullivan J , O'Brien C , Dark J. Which cyclosporin formulation. Lancet 1996; 348: 1177.

Trulock EP , Ettinger NA , Brunt EM , Pasaque MK , Kaiser LR , Cooper JD . The role of transbronchial lung biopsy in the treatment of lung transplant recipients. Chest 1992; 102: 1049–54.

Herve P , Silbert D , Cerrina J , Simmonneau G , Dartevelle P. Impairment of bronchial mucocilliary clearance in long term survivors of heart/lung and double lung transplantation. Chest 1993; 103: 59–63.

Higgenbottam T , Stewart S , Penketh A , Wallwork J. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation 1988; 46: 523–39.

Egan JJ , Barber L , Lomax J The detection of human cytomegalovirus antigenaemia a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients. Thorax 1995; 50: 9–13.

Egan JJ , Lomax J , Barber L Early targeted antiviral therapy for the prevention of CMV disease. J Heart Lung Transplant 1996; 15: S53.

Armitage JM , Kormos RL , Stuart S Post transplant lymphoproliferative disease in thoracic organ transplant patients: 10 years of cyclosporin based immunosuppression. J Heart Lung Transplant 1991; 10: 877–87.

Egan JJ , Stewart J , Yonan N , Arrand J , Woodcock AA . Non-Hodgkin lymphoma in heart/lung transplant recipients. Lancet 1994; 343: 481.

Opelz G , Henderson R. Incidence of non-Hodkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514–16.

Egan JJ , Haselton PS , Yonan N Necrotic, ulcerative bronchitis the presenting feature of lymphoproliferative disease following heart/lung transplantation. Thorax 1995; 50: 205–7.

Cooper JD , Billingham M , Egan T A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12: 713–6.

Patterson GM , Wilson S , Whang JL Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant 1996; 15: 175–81.

Farrell D , Healy M , Pritchard G , Dark JD , Corns PA . Lymphocyte infiltrates in bronchial biopsies from large airways in patients after lung transplantation. Eur Resp J 1995; 8: 450S.

Egan JJ , Sarker S , Hasleton PS , Yonan N , Deiraniya AK , Woodcock AA . Should cryptogenic organising pneumonia be included in the classification of lung allograft rejection. J Heart Lung Transplant 1996; 15: 1268–9.

Afolabi OA , Parry G , Healy MD , Corns PA , Dark JH . The role of total lymphoid irradiation (TLI) in the treatment of obliterative bronchiolitis—2 years on. J Heart Lung Transplant 1996; 15: S102.

Elborn JS , Shale DJ , Britton JR . Heart-lung transplantation in cystic fibrosis patients: predictions for the next decade. Respir Med 1994; 88: 135–8.

United Kingdom Transplant Support Services Authority. Fourth Annual Report of the Special Health Authority 1994-5.

Egan JJ , Webb K , Woodcock AA . Lung donors for cystic fibrosis patients. Thorax 1996; 51: 873.

Wight C , Cohen B. Shortage of organs for transplantation. BMJ 1996; 312: 989–90.

Matesanz R , Miranda B , Felipe C. Organ procurement in Spain: impact of transplant coordination. Clin Transplant 1994; 8: 281–6.

Barr ML , Schenkel FA , Cohen KM , Barbers RG , Marboe CC , Starnes VA . Living related lobar transplantation: recipient outcome and early rejection patterns. Transplantation Proc 1995; 27: 1995–6.